Jazz Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Jazz Pharmaceuticals exhibits at Booth 3429 at ASH 2026 in New Orleans. Jazz Pharmaceuticals supports a symposium on how to sequence treatment in acute lymphoblastic leukemia. Experts debate choices from asparaginase to cellular therapy, with minimal residual disease results steering decisions.
| Organization | ASH 2026 Attendance |
|---|---|
Jazz Pharmaceuticals Dublin, Ireland | |
Biopharmaceutical company with marketed medicines and pipeline candidates in neuroscience and oncology, including hematologic cancers. | Booth Exhibiting at Booth 3429 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm Medical Crossfire®: Strategic Sequencing in ALL — From Asparaginase to Cellular Therapy in an MRD-Driven Era Ordering acute lymphoblastic leukemia therapies, from asparaginase to bispecifics and CAR-T, guided by sensitive residual disease testing. |
Find decision makers at Jazz Pharmaceuticals
Tell us what you sell and we’ll find the people at Jazz Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction